Chemoinformaics analysis of 6-O-galloyl-beta-D-glucose
| Molecular Weight | 332.261 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.133 | nRig | 13 |
| Exact Molecular Weight | 332.074 | nRing | 2 |
| Solubility: LogS | -1.017 | nHRing | 1 |
| Solubility: LogP | -0.874 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 6 |
| nHA | 10 | APOL | 40.3987 |
| nHD | 7 | BPOL | 20.3913 |
| QED | 0.236 |
| Synth | 3.739 |
| Natural Product Likeliness | 1.7 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.883 |
| HIA | 0.846 |
| CACO-2 | -6.378 |
| MDCK | 0.0000279 |
| BBB | 0.258 |
| PPB | 0.767236 |
| VDSS | 0.582 |
| FU | 0.309878 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.028 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.117 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.014 |
| CL | 6.179 |
| T12 | 0.934 |
| hERG | 0.171 |
| Ames | 0.56 |
| ROA | 0.005 |
| SkinSen | 0.928 |
| Carcinogencity | 0.044 |
| EI | 0.697 |
| Respiratory | 0.021 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.529992 |